The Pharma Podcast

Support Health Partners Ukraine Relief efforts

On this episode of the PharmaPodcast my guest is Lois Brown, President of Health Partners International  of Canada.  Lois and I discuss Health Partners and its response to the Emergency in Ukraine.

Health Partners is actively responding to the crisis in Ukraine by providing Humanitarian Medical Kits to Ukrainians in-country and in neighbouring refugee camps.

Over the next few months, Health Partners aims to send 400 Humanitarian Medical Kits to provide urgently-needed medical relief, and need to raise $240,000 in order to mobilize these medicines.

Please support our efforts by making a donation to our ‘Ukraine Emergency Fund’ today.

https://hpicanada.ca/donate/

On this episode of The Pharma Podcast, my guest is Raj Indupuri, CEO, eClinical Solutions. 

Raj  and I explore the Build vs. Buy Pendulum: Should CROs buy technology capabilities or should they develop them in-house?” 

Contact Information:
Raj Indupuri
CEO
eClinical Solutions
[email protected]
tel. 508.594.6313

On this episode of the PharmaPodcast my guest is Michael Cloutier,  founding partner at Accelera Canada.   Mike has been CEO/President/GM of seven Canadian companies and affiliates including: Searle, Pharmacia, AstraZeneca, COTI, InterMune, PTC Therapeutics, Diabetes Canada! 

Mike and I discuss the current commercial landscape for pharma in Canada, including its challenges and opportunities.

Contact Information:
Michael Cloutier
Founding Partner
[email protected]
289-208-4191

210B-219 Dufferin Street,
Toronto, ON M6K 3J1

On this episode of the Pharma Podcast my guest is Nicole Serena, President and Managing Director at PSPConsult, a division of Waldron & Associates and co-founder of PSPCertify – a new Certification Program for PSP Professionals. 

Nicole and I discuss BioSimilars and the need for Patient Support Programs to support them.   

Contact Information:
Nicole Serena
President & Managing Director PSPConsult
A division of Waldron & Associates
[email protected]
www.pspconsult.ca

Ryan Clarke is CEO and founder of Advocacy Solutions and a Senior Partner at Accelera Canada, where he is responsible for Advocacy & Stakeholder Relations.

In this episode of The Pharma Podcast Ryan discusses CADTH (Canadian Agency for Drugs and Technologies in Health)  and the streamlined input processes for both patients and Clinicians.

Contact Information:
[email protected]

C: 416.919.9532 
Toll Free: 1.800.250.1569
219 Dufferin Street, Unit 210B, Toronto ON, M6K 3J1

On this episode of The Pharma Podcast my guest is Lindy Forte, Senior Partner, Health Technology Assessment at Accelera Canada .

Lindy discusses the Patented Medicines Pricing Review Board (PMPRB),  the amendments to the Patented Medicines Regulations and its impact on Drug prices in Canada.

She also shares her thoughts on what she likes about the new regulations, and some potential shortcomings.

This episode of the podcast is a must listen to for any pharma professional considering launching a new drug in Canada.

Contact Information:
www.acceleracanada.com
[email protected]

In this episode of the PharmaPodcast my guest is Vijay Wadhawan, Vice President, Health and Wellness at Environics Research.   

Getting fast, convenient access to healthcare can be frustrating for many Canadians. COVID19 has exacerbated existing challenges. Telemedicine is a new delivery channel for medicine with the potential to make healthcare more accessible.  

Vijay discusses the findings from a recent survey conducted by Environics Research to understand Canadian attitudes toward healthcare and telemedicine.   

Contact Information for Vijay Wadhawan:
linkedin.com/in/vwadhawan
[email protected]
https://environicsresearch.com/capabilities-insights/health-wellness/

In this episode of The Pharma Podcast, my guest is Brian Bloom, co-founder and CEO of Bloom Burton.   

Brian gives us a snap shot of the Canadian R&D landscape, its promise, and how Canadian innovation has been impacted by COVID-19 and how it is contributing to the fight against COVID-19. 

Brian is a true champion of our industry. To bring any new therapy to market requires a good idea, bright minds and a lot of money.   

Brian and his team at Bloom Burton have helped a lot of smart people with bright ideas find the money to fund their dreams and bring new therapies to patients.   

This podcast was  recorded on the heels of the 2020 Bloom Burton Award Gala hosted by Brian and his business partner, and fellow co-founder, Jolyon Burton. The award gala highlights what is possible when we fund smart people with bright ideas. 

Several COVID19 vaccine candidates are in development and launch plans are being drafted. 

Progress is unfolding at an unprecedented pace. More than 200 potential vaccines are in development and more than 40 have entered human trials.  Applications for approval have  already been submitted to Health Canada under the Interim Order. 

Canada, currently, has access to a guaranteed 174 million doses of potential COVID19 vaccines. This represents over $1 billion in advance purchase agreements  

Canada has also pledged to the World Health Organisation's Advanced Market Commitment (AMC) $220 million to purchase 15 million vaccine doses from the COVAX facility plus $220 million to purchase doses for low- and middle-income countries. 

Securing regulatory approval and supply agreements is a great first step, but how will the vaccine be rolled out safely and  equitable as possible?

To help us understand how industry in Canada is preparing for the roll out, I’ve invited  Daniel Chiasson, President and CEO, of the Canadian Association for Pharmacy Distribution Management (CAPDM). 

In this episode of The Pharma Podcast  we discuss Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19. 

My guest is Tiana DiMichele, Director, Business Development, Impres Inc.

Contact Information:
Tiana DiMichele, Director, Business Development
Phone: (416) 885-0023 |
E-mail: [email protected]